← Open Payments lookup

RODNEY HUFF: Open Payments

NPI 1205870490 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,080 in 59 payments from 25 companies in 2025. Trend: 2023 $1,743 · 2024 $890 · 2025 $3,080

Food & beverage: $2,218Consulting: $750Education: $112
CompanyPaymentsAmount
Daiichi Sankyo Inc.4$922
Gilead Sciences, Inc.9$358
AstraZeneca Pharmaceuticals LP6$301
Amgen Inc.2$186
Janssen Biotech, Inc.4$171
Immunocore Limited2$144
E.R. Squibb & Sons, L.L.C.1$130
Lilly USA, LLC3$125
Smith+Nephew, Inc.1$122
Takeda Pharmaceuticals U.S.A., Inc.3$82

Products named: DATROWAY, Trodelvy, IMDELLTRA (AMG757), RYBREVANT, KIMMTRAK, OPDIVO, GRAFIX PL, NINLARO.

Industry payments across VA — which companies pay providers there.